Literature DB >> 9358945

Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity.

P Walker1, S Watanabe, P Lawlor, J Hanson, J Pereira, E Bruera.   

Abstract

The logistics of administering intravenous bisphosphonates may be problematic in the care of advanced cancer patients, especially in the home setting. Hypodermoclysis is a convenient method of administering fluid via subcutaneous infusion, presently used in the domiciliary setting. Results of the administration of clodronate via this route are reported.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358945     DOI: 10.1023/a:1008274608267

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  5 in total

Review 1.  Emergencies of calcium homeostasis.

Authors:  Jean-Jacques Body; Roger Bouillon
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients.

Authors:  A Frisoli Junior; A P de Paula; D Feldman; F Nasri
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

3.  Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study.

Authors:  H K Marr; C R Stiles; M A Boyar; T C Braun; N A Hagen; C Janzen; L M Whitten; J L Pereira
Journal:  Curr Oncol       Date:  2010-04       Impact factor: 3.677

Review 4.  Clodronic acid formulations available in Europe and their use in osteoporosis: a review.

Authors:  Bruno Frediani; Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

5.  Subcutaneous Infusion of Pamidronate in a Hospice Patient with Hypercalcemia: A Case Report.

Authors:  Chris Vandevelde; Jordan Ho
Journal:  Can J Hosp Pharm       Date:  2021-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.